Fairmount Funds Management LLC Top Holdings and 13F Report (2021) → Kiss of death from Joe Biden (From Porter & Company) (Ad) About Fairmount Funds Management LLCInvestment ActivityFairmount Funds Management LLC has $917.39 million in total holdings as of September 30, 2021.Fairmount Funds Management LLC owns shares of 15 different stocks, but just 8 companies or ETFs make up 80% of its holdings.Approximately 12.57% of the portfolio was purchased this quarter.About 38.75% of the portfolio was sold this quarter.This quarter, Fairmount Funds Management LLC has purchased 16 new stocks and bought additional shares in 5 stocks.Fairmount Funds Management LLC sold shares of 1 stock and completely divested from 3 stocks this quarter.Largest Holdings Axsome Therapeutics $188,334,145Nuvalent $144,520,166APOGEE THERAPEUTICS INC $136,132,593DIANTHUS THERAPEUTICS INC $82,885,110Kiniksa Pharmaceuticals $63,231,513 Largest New Holdings this Quarter Protagonist Therapeutics $26,959,578 HoldingGeron $22,000,001 Holding Largest Purchases this Quarter Protagonist Therapeutics 931,890 shares (about $26.96M)DIANTHUS THERAPEUTICS INC 834,334 shares (about $25.03M)Geron 6,666,667 shares (about $22.00M)Enliven Therapeutics 1,071,429 shares (about $18.85M)Viridian Therapeutics 476,190 shares (about $8.34M) Largest Sales this Quarter APOGEE THERAPEUTICS INC 892,529 shares (about $59.31M) Sector Allocation Over TimeMap of 500 Largest Holdings ofFairmount Funds Management LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorAXSMAxsome Therapeutics$188,334,1450.0%2,360,07720.5%MedicalNUVLNuvalent$144,520,1660.0%1,924,62615.8%MedicalAPOGEE THERAPEUTICS INC$136,132,593$59,308,552 ▼-30.3%2,048,64714.8%COMDIANTHUS THERAPEUTICS INC$82,885,110$25,030,020 ▲43.3%2,762,8379.0%COMKNSAKiniksa Pharmaceuticals$63,231,513$6,345,563 ▲11.2%3,204,8416.9%MedicalELVNEnliven Therapeutics$56,337,217$18,846,436 ▲50.3%3,202,7986.1%MedicalATXSAstria Therapeutics$50,024,3660.0%3,554,1295.5%MedicalVRDNViridian Therapeutics$32,320,186$8,338,087 ▲34.8%1,845,8133.5%MedicalMRUSMerus$32,297,9480.0%717,2543.5%MedicalCOGTCogent Biosciences$31,756,308$7,839,996 ▲32.8%4,725,6413.5%MedicalPTGXProtagonist Therapeutics$26,959,578$26,959,578 ▲New Holding931,8902.9%MedicalTYRATyra Biosciences$22,850,5960.0%1,393,3292.5%MedicalGERNGeron$22,000,001$22,000,001 ▲New Holding6,666,6672.4%MedicalSPYRE THERAPEUTICS INC$14,353,5090.0%378,4211.6%COM NEWTERNTerns Pharmaceuticals$13,382,4000.0%2,040,0001.5%MedicalIMGNImmunoGen$0$175,812,403 ▼-100.0%00.0%MedicalRAYZEBIO INC$0$77,459,406 ▼-100.0%00.0%COMARGXargenx$0$42,951,688 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data: SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
